EOLS Return on Tangible Equity | EVOLUS, INC.

EVOLUS, INC. (EOLS) Return on Tangible Equity

2026-06-30: Return Tang Equity 35.10%.
2026-03-31: Return Tang Equity 44.89%.
2025-12-31: Return Tang Equity 55.92%.
2025-09-30: Return Tang Equity 59.34%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	35.10%
2026-03-31	44.89%
2025-12-31	55.92%
2025-09-30	59.34%
2025-06-30	69.50%
2025-03-31	72.83%
2024-12-31	78.24%
2024-09-30	89.59%
2024-06-30	110.47%
2024-03-31	121.57%
2023-12-31	69.30%
2023-09-30	72.37%
2023-06-30	88.04%
2023-03-31	115.30%
2022-12-31	145.04%
2022-09-30	193.27%
2022-06-30	330.70%
2022-03-31	1771.34%
2021-12-31	-466.10%
2021-09-30	-563.44%
2021-06-30	-402.68%
2021-03-31	265.85%
2020-12-31	109.07%
2020-09-30	155.76%
2020-06-30	231.14%
2020-03-31	555.77%
2019-12-31	6481.93%
2019-09-30	137.40%
2019-06-30	185.57%
2019-03-31	1501.02%
2018-12-31	-662.34%
2018-09-30	-169.76%
2018-06-30	52.78%
2018-03-31	26.23%
2017-12-31	2.93%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	55.92%
2024-12-31	78.24%
2023-12-31	69.30%
2022-12-31	145.04%
2021-12-31	-466.10%
2020-12-31	109.07%
2019-12-31	6481.93%
2018-12-31	-662.34%
2017-12-31	2.93%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CRESCENT BIOPHARMA, INC. (CBIO)	United States	$0.529B	-5.20
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)	United States	$0.507B	15.53
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
CAPRICOR THERAPEUTICS, INC. (CAPR)	United States	$0.499B	-10.81
Ovid Therapeutics Inc. (OVID)	United States	$0.487B	-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
MapLight Therapeutics, Inc. (MPLT)	United States	$0.459B	-7.10
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43